Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Non-Current Debt (2020 - 2025)

PROCEPT BioRobotics has reported Non-Current Debt over the past 6 years, most recently at $51.6 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $51.6 million for Q4 2025, changed 0.28% from a year ago — trailing twelve months through Dec 2025 was $51.6 million (changed 0.28% YoY), and the annual figure for FY2025 was $51.6 million, changed 0.28%.
  • Non-Current Debt for Q4 2025 was $51.6 million at PROCEPT BioRobotics, roughly flat from $51.6 million in the prior quarter.
  • Over the last five years, Non-Current Debt for PRCT hit a ceiling of $51.6 million in Q4 2025 and a floor of $49.8 million in Q3 2021.
  • Median Non-Current Debt over the past 5 years was $51.3 million (2023), compared with a mean of $51.1 million.
  • Biggest five-year swings in Non-Current Debt: grew 12.6% in 2021 and later rose 0.23% in 2025.
  • PROCEPT BioRobotics' Non-Current Debt stood at $50.0 million in 2021, then increased by 2.42% to $51.2 million in 2022, then grew by 0.25% to $51.3 million in 2023, then increased by 0.26% to $51.5 million in 2024, then rose by 0.28% to $51.6 million in 2025.
  • The last three reported values for Non-Current Debt were $51.6 million (Q4 2025), $51.6 million (Q3 2025), and $51.5 million (Q2 2025) per Business Quant data.